These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35360461)

  • 81. Previous exposure to measles, mumps, and rubella--but not vaccination during adolescence--correlates to the prevalence of pancreatic and thyroid autoantibodies.
    Lindberg B; Ahlfors K; Carlsson A; Ericsson UB; Landin-Olsson M; Lernmark A; Ludvigsson J; Sundkvist G; Ivarsson SA
    Pediatrics; 1999 Jul; 104(1):e12. PubMed ID: 10390298
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
    Wanlapakorn N; Puenpa J; Thongmee T; Srimuan D; Thatsanathorn T; Vongpunsawad S; Poovorawan Y
    Vaccine; 2020 May; 38(24):4016-4023. PubMed ID: 32331806
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Correlations between measles, mumps, and rubella serum antibody levels in Olmsted County school children.
    St Sauver JL; Jacobson RM; Vierkant RA; Jacobsen SJ; Green EM; Schaid DJ; Poland GA
    Vaccine; 2001 Jan; 19(11-12):1363-8. PubMed ID: 11163657
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A randomised single blind trial of a combined mumps measles rubella vaccine to evaluate serological response and reactions in the UK population.
    Edees S; Pullan CR; Hull D
    Public Health; 1991 Mar; 105(2):91-7. PubMed ID: 2068243
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine.
    Fasano MB; Wood RA; Cooke SK; Sampson HA
    J Pediatr; 1992 Jun; 120(6):878-81. PubMed ID: 1593346
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM; Baker L; Starr SE; Plotkin SA
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Revaccination with measles-mumps-rubella vaccine and hospitalization for infection in Denmark and Sweden - An interrupted time-series analysis.
    Sørup S; Englund H; Laake I; Nieminen H; Gehrt L; Feiring B; Trogstad L; Roth A; Benn CS
    Vaccine; 2022 Mar; 40(11):1583-1593. PubMed ID: 33518465
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
    Leung JH; Hirai HW; Tsoi KK
    Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.
    Marin M; Fiebelkorn AP; Bi D; Coleman LA; Routh J; Curns AT; McLean HQ
    Clin Infect Dis; 2021 Oct; 73(7):e1546-e1553. PubMed ID: 32766827
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration.
    MMR-158 Study Group
    Hum Vaccin Immunother; 2019; 15(4):786-799. PubMed ID: 30785357
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Lack of adverse reactions to measles, mumps, and rubella vaccine in egg-allergic children.
    Freigang B; Jadavji TP; Freigang DW
    Ann Allergy; 1994 Dec; 73(6):486-8. PubMed ID: 7998661
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school.
    Jiles RB; Fuchs C; Klevens RM
    MMWR CDC Surveill Summ; 2000 Sep; 49(9):27-38. PubMed ID: 11016876
    [TBL] [Abstract][Full Text] [Related]  

  • 94. MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland.
    Johnson H; Hillary IB; McQuoid G; Gilmer BA
    Vaccine; 1995 Apr; 13(6):533-7. PubMed ID: 7483773
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM
    An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy.
    Perfetto B; Paduano G; Grimaldi E; Sansone V; Donnarumma G; Di Giuseppe G
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543969
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Spectrometric Analysis of Dantrolene Sodium.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; McGuire C; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 37424832
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Spectral Intra-Lot and Inter-Lot Variability in Carfilzomib.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Anwar H; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 37008539
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Potential Process Control Issues with Pemetrexed.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
    Contact Context; 2022; 2022():. PubMed ID: 35967958
    [TBL] [Abstract][Full Text] [Related]  

  • 100. FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply.
    Almeter PJ; Isaacs JT; Hunter AN; Henderson BS; Platt T; Mitchell BJ; Do D; Brainard AB; Brown JE; Stone RM; Nguyen BH; Warren MF; Bhaktawara SA; Bossle MN; Long LM; Zapata SP; Larkin CR; Lyman TA; Larkin SA; Labuhn JA; Reynolds JW; Schuler EE; Naseman RW; Johnson GL; Lodder RA
    J Pharm Innov; 2022; 17(2):269-282. PubMed ID: 35677914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.